Medically reviewed by Derek Wimmer, PA
Wharton's jelly is the stem-cell-rich connective tissue from donated, screened umbilical cords, rich in structural proteins and signaling components found in young tissue. At Wimmer it is injected — with image guidance (ultrasound or fluoroscopy) when it adds precision — into joints or soft tissue as part of a regenerative care plan. It is an allograft biologic, and candidacy is determined at an in-person evaluation with written informed consent.
| Type | Stem cell allograft biologic |
|---|---|
| Source | Donated, screened umbilical cord tissue |
| Doses | 70mg and 300mg |
| Guidance | Ultrasound or fluoroscopy, when needed |
| First results | Gradual over weeks to months |
What is Wharton's jelly?
Wharton's jelly is the protective connective tissue that surrounds the blood vessels inside the umbilical cord. It is naturally rich in the structural proteins, hyaluronic acid, and signaling components characteristic of very young tissue.
The product we use comes from healthy, consented, screened donors after scheduled deliveries, processed by accredited tissue facilities — sourcing documentation we are glad to discuss with you.
How it's used at Wimmer
For selected patients, Wharton's jelly is injected — with image guidance (ultrasound or fluoroscopy) when it adds precision — into a joint or soft-tissue area as part of an individualized regenerative plan. It is most often discussed for arthritic joints such as the knee, hip, and shoulder, in patients seeking alternatives to surgery.
- Image-guided delivery when it adds precision
- Available in 70mg and 300mg doses, matched to the area treated
- Often coordinated with exosomes, peptides, PRP, or focused shockwave in a broader plan
- Candidacy confirmed at an in-person evaluation
Honest expectations
Responses to biologic injections vary from person to person, and results are not guaranteed. Research on umbilical-derived allografts is ongoing, and we will give you a candid assessment of the current evidence as it applies to your diagnosis — and tell you plainly if we think another option fits you better.
Informed, individualized care
Notice: Regenerative biologics, including Wharton's jelly allografts, are individualized therapies, and we provide detailed written informed consent covering the nature of the treatment, its risks and potential benefits, and your alternatives, including non-treatment. You are encouraged to consult with your primary care physician as part of your decision, and we're glad to review the sourcing documentation with you.
Frequently asked questions
Wharton's jelly is a stem-cell-rich, umbilical-derived allograft tissue product. We explain honestly what the product we use contains and does not contain, and review the sourcing documentation with you.
Responses to biologic injections are gradual and vary by person — many patients notice change over the weeks to a few months following treatment. Results are not guaranteed, and we set honest expectations up front.
The tissue comes from healthy, screened, consented donors and is processed at accredited facilities. As with any injection there are risks, which we review during your informed-consent discussion.
Regenerative biologics are private-pay. We publish transparent pricing, accept CareCredit, and discuss costs openly before any treatment.
Candidacy depends on your diagnosis, imaging, and goals. It starts with an in-office evaluation, with imaging when needed, directly with Derek Wimmer.
